Literature DB >> 10880311

Peripherally inserted central catheters in patients with AIDS are associated with a low infection rate.

D J Skiest1, M Abbott, P Keiser.   

Abstract

We reviewed the medical records of all human immunodeficiency virus (HIV)-infected patients who had a peripherally inserted central catheter (PICC) placed during a 1-year period. Ninety-seven PICCs were inserted in 66 patients for 8337 catheter-days. Eighty of 97 catheters were used primarily to treat cytomegalovirus disease. The mean time to any complication was 150 days. The total complication rate was 6.1 per 1000 catheter-days. The total infection rate was 1. 3 per 1000 catheter-days, and the serious infection rate was 0.8 per 1000 catheter-days. The mean time to a serious infection was 310 days. The noninfectious complication rate was 4.6 per 1000 catheter-days. PICCs were associated with a low infection rate and a moderate mechanical complication rate, which compare favorably with historical rates seen in AIDS patients with other types of central venous access devices. PICCs are a reasonable alternative to other central venous access devices in patients with HIV or AIDS.

Entities:  

Mesh:

Year:  2000        PMID: 10880311     DOI: 10.1086/313822

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  5 in total

1.  Long-term use of peripherally inserted central venous catheters for cancer chemotherapy in children.

Authors:  Akinobu Matsuzaki; Aiko Suminoe; Yuhki Koga; Miho Hatano; Sagano Hattori; Toshiro Hara
Journal:  Support Care Cancer       Date:  2005-07-06       Impact factor: 3.603

2.  A role for peripherally inserted central venous catheters in the prevention of catheter-related blood stream infections in patients with hematological malignancies.

Authors:  Toshiro Sakai; Kyuhei Kohda; Yuichi Konuma; Yasuko Hiraoka; Yukari Ichikawa; Kaoru Ono; Hiroto Horiguchi; Ayumi Tatekoshi; Kouichi Takada; Satoshi Iyama; Junji Kato
Journal:  Int J Hematol       Date:  2014-09-24       Impact factor: 2.490

3.  epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England.

Authors:  H P Loveday; J A Wilson; R J Pratt; M Golsorkhi; A Tingle; A Bak; J Browne; J Prieto; M Wilcox
Journal:  J Hosp Infect       Date:  2014-01       Impact factor: 3.926

4.  Peripherally inserted central catheter bloodstream infection surveillance rates in an acute care setting in Saudi Arabia.

Authors:  Jaffar A Al-Tawfiq; Mahmoud S Abed; Ziad A Memish
Journal:  Ann Saudi Med       Date:  2012 Mar-Apr       Impact factor: 1.526

5.  Thrombolytic Therapy Using Urokinase for Management of Central Venous Catheter Thrombosis.

Authors:  Jung Tack Son; Sun Young Min; Jae Il Kim; Pyong Wha Choi; Tae Gil Heo; Myung Soo Lee; Chul-Nam Kim; Hong-Yong Kim; Seong Yoon Yi; Hye Ran Lee; Young-Nam Roh
Journal:  Vasc Specialist Int       Date:  2014-12-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.